Stay updated with breaking news from Coreys Goodman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Park Avenue Securities LLC cut its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 19.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,698 shares of the biotechnology company’s stock after selling 2,984 shares during the period. […]
OKYO Pharma (NASDAQ:OKYO – Get Rating) and Exelixis (NASDAQ:EXEL – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Profitability This table compares OKYO Pharma and Exelixis’ net margins, return […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Exelixis, Inc. (NASDAQ:EXEL – Get Rating) EVP Patrick J. Haley sold 10,000 shares of the business’s stock in a transaction dated Thursday, March 31st. The shares were sold at an average price of $22.43, for a total value of $224,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which […]
Exelixis, Inc. (NASDAQ:EXEL – Get Rating) has received an average recommendation of “Buy” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and one has issued a strong buy […]